Pharmacoepidemiology and Drug Safety
The course will cover key issues in pharmacoepidemiologic and drug safety research.
With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of ‘safety’, proof of
‘effectiveness’). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs ‘efficacy’.
The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.
You will experience an intensive programme covering the following topics: Study Design and Methods; Confounding and other biases; Methods in drug
safety research; Drug Safety and Risk Management; Overview of
Pharmacoepidemiological databases; Molecular Pharmacoepidemiology; Drug utilization research; Synthesis, case studies & public health.
Prof. O.H. Klungel
Prof. S. Suissa, Prof. H.G.M. Leufkens, Prof. A. de Boer, Prof. A.C.G., Egberts, Prof. O.H. Klungel, Prof. T.P. van Staa, Dr. F. de Vries
Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in the policy
aspects of pharmaceuticals, pharmacoepidemiology and/or pharmacoeconomics.
Students will learn about the typical problems and approaches to deal with these problems in the practice of pharmacoepidemiology.
1 week fulltime
• € 1150 - Course + course materials + housing
• € 950 - Course + course materials
The fee includes lunches and one course dinner.
This course can be combined with course M7 (Pharmaceutical Policy Analysis) and/or M14 (Pharmacoeconomics). Combination fee for two courses is €1500,- (excluding housing), combination fee for all three courses combined is €1950,- (excluding housing)
The course Pharmacoepidemiology and Drug Safety can be combined with the following courses.
Pharmaceutical Policy Analysis
10-07-2017 - 14-07-2017 | 1.5 ECTS | € 1150
17-07-2017 - 21-07-2017 | 1.5 ECTS | € 1150
Utrecht Summer School doesn't offer scholarships for this course.
Prof. dr. Olaf Klungel
P: +31 6 288 31 313
For summer school participants interested in the topic of Pharmacoepidemiology and Drug Safety this Elevate course by Prof. dr. Olaf Klungel could be interesting as well: Go to Elevate website .
» Contact Utrecht Summer School
Deadline for registration: 01 June 2017